Overview

Study of Tamibarotene in Patients With ADPKD

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
Clinical trial of tamibarotene in patients with Autosomal Dominant Polycystic Kidney Disease
Phase:
PHASE2
Details
Lead Sponsor:
Rege Nephro Co., Ltd.
Treatments:
tamibarotene